{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:35:10Z","timestamp":1772120110990,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,5,3]],"date-time":"2008-05-03T00:00:00Z","timestamp":1209772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s15010-007-7132-6","type":"journal-article","created":{"date-parts":[[2008,5,5]],"date-time":"2008-05-05T05:02:23Z","timestamp":1209963743000},"page":"250-255","source":"Crossref","is-referenced-by-count":39,"title":["Incidence of Neutropenia and Infections During Combination Treatment of Chronic Hepatitis C with Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin"],"prefix":"10.1007","volume":"36","author":[{"given":"M. G.","family":"Antonini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Babudieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Maida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Baiguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Zanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fenu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dettori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Manno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Mura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Carosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Puoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,3]]},"reference":[{"key":"7132_CR1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","volume":"39","author":"DB Strader","year":"2004","unstructured":"Strader DB, Wright T, Thomas DL and Seeff LB (2004). American Association for the Study of Liver Diseases: diagnosis, management, and treatment of hepatitis C. Hepatology 39: 1147\u20131171","journal-title":"Hepatology"},{"key":"7132_CR2","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1002\/hep.1840360730","volume":"36","author":"MW Fried","year":"2002","unstructured":"Fried MW (2002). Side effects of therapy of hepatitis C and their management. Hepatology 36: S237\u2013S244","journal-title":"Hepatology"},{"key":"7132_CR3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/135965350400900417","volume":"9","author":"M Puoti","year":"2004","unstructured":"Puoti M, Babudieri S, Rezza G, Viale P, Antonini MG, Maida I, Rossi S, Zanini B, Putzolu V, Fenu L, Baiguera C, Sassu S, Carosi G and Mura MS (2004). Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?. Antivir Ther 9: 627\u2013630","journal-title":"Antivir Ther"},{"key":"7132_CR4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1053\/jhep.2002.36502","volume":"36","author":"A Soza","year":"2002","unstructured":"Soza A, Everhart JE, Ghany MG, Doo E, Heller T, Promrat K, Park Y, Liang TJ and Hoofnagle JH (2002). Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C. Hepatology 36: 1273\u20131279","journal-title":"Hepatology"},{"key":"7132_CR5","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1086\/504386","volume":"42","author":"CL Cooper","year":"2006","unstructured":"Cooper CL, Al-Bedwawi S, Lee C and Garber G (2006). Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia. Clin Infect Dis 42: 1674\u20131678","journal-title":"Clin Infect Dis"},{"key":"7132_CR6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/135965350400900405","volume":"9","author":"R Bruno","year":"2004","unstructured":"Bruno R, Sacchi P, Ciappina V, Zochetti C, Patruno S, Maiocchi L and Filice G (2004). Viral dynamics and pharmacokinetics of peginterferon alpha-2a and peginterferon alpha-2b in naive patients with chronic hepatitis c: a randomized, controlled study. Antivir Ther 9: 491\u2013497","journal-title":"Antivir Ther"},{"key":"7132_CR7","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1098-3597(06)80053-0","volume":"8","author":"LS Schwartzberg","year":"2006","unstructured":"Schwartzberg LS (2006). Neutropenia: etiology and pathogenesis. Clin Cornerstone 8: S5\u2013S11","journal-title":"Clin Cornerstone"},{"key":"7132_CR8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2036.2004.02170.x","volume":"20","author":"GR Foster","year":"2004","unstructured":"Foster GR (2004). Pegylated interferons: chemical and clinical differences. Aliment Pharmacol Ther 20: 825\u2013830","journal-title":"Aliment Pharmacol Ther"},{"key":"7132_CR9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1358\/mf.2005.27.5.908646","volume":"27","author":"A Juarez-Navarro","year":"2005","unstructured":"Juarez-Navarro A, Vera-de-Leon L, Navarro JM, Chirino-Sprung R, Diaz-Hernandez M, Casillas-Davila L and Dehesa-Violante M (2005). Incidence and severity of infections according to the development of neutropenia during combined therapy with pegylated interferon-alpha2a plus ribavirin in chronic hepatitis C infection. Methods Find Exp Clin Pharmacol 27: 317\u2013322","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"7132_CR10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/gut.2004.057893","volume":"54","author":"M Schmid","year":"2005","unstructured":"Schmid M, Kreil A, Jessner W, Homoncik M, Datz C, Gangl A, Ferenci P and Peck-Radosavljevic M (2005). Suppression of hematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens. Gut 54: 1014\u20131020","journal-title":"Gut"},{"key":"7132_CR11","unstructured":"PEG-lntron\u00ae: Peginterferon alfa-2b, recombinant [package insert]. Schering Corporation, Kenilworth 2002"},{"key":"7132_CR12","unstructured":"Pegasys\u00ae: Peginterferon alfa-2a [package insert]. Hoffmann-La Roche, Inc., Nutley, NJ 2002"},{"key":"7132_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0168-3659(01)00402-3","volume":"75","author":"P Laverman","year":"2001","unstructured":"Laverman P, Dams ET, Storm G, Hafmans TG, Croes HJ, Oyen WJ, Corstens FH and Boerman OC (2001). Microscopic localization of PEG-liposomes in a rat model of focal infection. J Control Release 75: 347\u2013355","journal-title":"J Control Release"},{"key":"7132_CR14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/135965350501000502","volume":"10","author":"A Cascio","year":"2005","unstructured":"Cascio A, Antinori S, Ricciardi F, Costantino G and Iaria C (2005). Visceral leishmaniasis during pegylated interferon therapy for chronic hepatitis C: first report. Antivir Ther 10: 695\u2013696","journal-title":"Antivir Ther"},{"key":"7132_CR15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00005792-197903000-00002","volume":"58","author":"DC Dale","year":"1979","unstructured":"Dale DC, Guerry IV D and Wewerka JR, et al. (1979). Chronic neutropenia. Medicine (Baltimore) 58: 128\u2013144","journal-title":"Medicine (Baltimore)"},{"key":"7132_CR16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1474-9728.2004.00110.x","volume":"3","author":"T Fulop","year":"2004","unstructured":"Fulop T, Larbi A, Douziech N, Fortin C, Guerard KP, Lesur O, Khalil A and Dupuis G (2004). Signal transduction and functional changes in neutrophils with aging. Aging Cell 3: 217\u2013226","journal-title":"Aging Cell"},{"key":"7132_CR17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0047-6374(03)00017-4","volume":"124","author":"AK Schroder","year":"2003","unstructured":"Schroder AK and Rink L (2003). Neutrophil immunity of the elderly. Mech Ageing Dev 124: 419\u2013425","journal-title":"Mech Ageing Dev"},{"key":"7132_CR18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","volume":"64","author":"GP Bodey","year":"1966","unstructured":"Bodey GP, Buckley M, Sathe YS and Freireich EJ (1966). Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328\u2013340","journal-title":"Ann Intern Med"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-007-7132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-007-7132-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-007-7132-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T21:15:24Z","timestamp":1738185324000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-007-7132-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["7132"],"URL":"https:\/\/doi.org\/10.1007\/s15010-007-7132-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718020312.793478814","asserted-by":"object"}]},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,3]]}}}